4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-26-002112
CEO and CFO bought 2,900 shares at $27.54 ($79,866)
From the SEC's structured data for this filing
Trades in this filing
Patel Snehal · CEO and CFO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-12 | Purchase : show line 1 in the form | +2,900 | $27.54 | $79,866 | 5,602,302 | D |
| Open-market purchases · 2,900 sh · avg $27.54 · $79,866 | ||||||
Loading xslF345X05/ownership.xml…